Sinopharm Group upgraded to hold from sell at UOB Kay Hian Securities (HK$19.34, 0.00)
Sinopharm Group reports 9M net income attributable CNY5.31B vs year-ago CNY5.28B (HK$19.57, 0.00)
StreetAccount Summary - Trading higher/lower: Hong Kong mid-morning
Sinopharm Group downgraded to neutral from outperform at ICBC International (HK$18.90, 0.00)
Street Takeaways - Sinopharm Group H1 earnings (HK$19.91, 0.00)
Powered by FactSet Research Systems Inc.